By Admin 
Finance Minister Nirmala Sitharaman held a press conference on Wednesday (03 September) after the 56th meeting of the GST Council. In this, he announced to reduce the GST from 12% on 33 life saving medicines, giving great relief to the patients. These drugs include medicines of many serious diseases including cancer. Apart from this, GST has been zero with 5 % on three other life saving medicines. Also, GST has been given 5 % from 12 % on other medicines. Let’s know how much will you save from this?
Relief on these medicines
The GST Council zero GST from 12% on 33 drugs. These drugs are mainly used in the treatment of cancer, rare genetic disorder, autoimmune disease and other serious diseases. Among them, agalSidase beta, immiglucease, eptacog alfa activated recombinant coagulation factor viia, onasemnoegene abparvovec, asciminib, mepoolizumab, pegylated liposomal irinotecocan, dartumumab, Daratumumab subcutaneous, tecclistamab, amivantamab, alectinib, risdiplam, obinutzumab, polatuzumab vedotin, entrectinib, atezolizumab, sphesolimab, velagluacese alpaha, agalsidase alpaha, agalsidase alpaha, etc. Rurioctocog alpha pegol, Idursulphatase, alglucosidase Alfa, Laronidase, Olipudase Alfa, Tepotinib, Avelumab, Emicizumab, Belumosudil, Miglustat, Velmanasese ALFA, alfa, alfa, alfa, Evolocumab, Cystamine Bitartrate, CI-Inhibitor Injection and Inclisiran. Adi medicines are included.
These cancer medicines become cheap
At the same time, daratumumab (for multiple myeloma), alectinib (lung cancer), obinutzumab (blood cancer), polatuzumab vedotin (lymphoma), entrectinib (solid tumor), atezolizumab (lung and bladder cancer), tepotinib (lung cancer) and awelumab (lung cancer) Cancer) GST has also been cut. Also, GST has also been zero on rare diseases such as Gauchar Disease Alpha (velaglucese alpha), pompe disease (alglucosidase Alfa) and hemicizumab. Also, GST on three drugs agalsidase beta, immiglucease and eptacog Alfa was zero from 5%. The Finance Minister said that these drugs are imported and expensive. GST deduction will increase their reach. Let us know that every year 14 lakh new cases of cancer occur in India. Patients will get a lot of relief due to decrease in GST on these medicines.
Which medicine will be cheap?
The GST deduction will directly affect the monthly bill of patients. We calculate some major cancer drug market values (without an estimated base price without GST) how much you will save now.
- Daratumumab (for multiple myeloma cancer): It comes in injection form. The base price of its monthly dose (about 4 vial) is two lakh rupees. Earlier, according to 12 % GST, it was taxed at 24 thousand, due to which this medicine used to be 2.24 lakhs.
- Alexiab (for lung cancer): The monthly pack of this drug coming in the capsule form comes from 60 capsules, whose base price is Rs 1.50 lakh. It used to cost Rs 1.68 lakh, including 12 % GST, which will now save.
- Osimertinib (for lung cancer): The monthly pack (30 tablet) of this 80mg tablet had to spend about Rs 1.51 lakh with 12 % GST. Now there will be a savings of Rs 16,200 every month. It is the first-line treatment for patients with EGFR mutations.
How much will be saved?
If a cancer patient is dependent on one or more of these medicines, then there is a hope of savings of 15 thousand to 50 thousand rupees in their monthly bill. On average, these 33 drugs are expected to save from 10 to 20 % every month, as some medicines are already subsidized.
Also read: How much will the house expenses be done every month after GST cut? Know the account according to ghee-oil and salt
Check out Below Health Tools-
Calculate your body mass index (BMI)
Calculate the age through age calculator